Impact of SARS-CoV-2 on neuropsychiatric disorders

doi:10.5498/wjp.v11.i7.347

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6215)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

582

WORD

117

HTML

3331

Figures (1-1)

229

Sum=4259

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

346

Download

565

Sum=911

Publishing Process of This Article

Item

Count

Browse

341

Download

704

Sum=1045

Jul 19, 2021 (publication date) through May 12, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Psychiatr. Jul 19, 2021; 11(7): 347-354
Published online Jul 19, 2021. doi: 10.5498/wjp.v11.i7.347

Open in New Tab Full Size Figure Download Figure

Figure 1 Immunological mechanisms of neuropsychiatric manifestations derived from severe acute respiratory syndrome coronavirus 2 infection. COVID-19: Coronavirus disease 2019; CNS: Central nervous system; NPM: Neuropsychiatric manifestation; M: Macrophages; BBB: Blood-brain barrier; GMCSF: Granulocyte-colony stimulating factor; IL: Interleukin; TNF: Tumor necrosis factor.

Citation: Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, Siniscalco D, García García RJ. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatr 2021; 11(7): 347-354
URL: https://www.wjgnet.com/2220-3206/full/v11/i7/347.htm
DOI: https://dx.doi.org/10.5498/wjp.v11.i7.347